Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
– Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research – Helps modify difficult-to-access regions of the genome, increasing genome coverage DARMSTADT, Germany, Feb. 19,…